Biotech Vanda Pharmaceuticals Announces Participation in the B. Riley Securities 2026 Mind, Muscle & Vision Summit July 25, 2026
Biotech Q32 Bio to Report 36-Week Topline Results from Part B of SIGNAL-AA Clinical Trial of Bempikibart in Alopecia Areata on July 13, 2026 July 24, 2026
Biotech Virax Biolabs Group Limited Announces Closing of Exercise of Preferred Investment Options for $3.3 Million Gross Proceeds July 23, 2026
Biotech NeuroTherapia to Present Phase 2a Alzheimer’s Disease Clinical Data at the AAIC 2026 Conference in London, UK July 22, 2026
Biotech Leads Biolabs Announces Multiple Studies Selected for ESMO 2026, Highlighting the Growing Global Competitiveness of Its Core Pipeline July 21, 2026
Biotech Boostimmune Secures Japanese Patent for Sequence-Independent TCTP Antibody Technology Targeting MDSC Accumulation July 20, 2026
Biotech HitGen Partner BioAge Labs Doses First Participant in Phase 2 Trial of BGE-102, a Novel Oral NLRP3 Inhibitor for Cardiovascular Risk Reduction July 19, 2026
Biotech Dizal Announces Global Exclusive License Agreement with AstraZeneca for Zegfrovy July 18, 2026
Biotech Harbour BioMed and Kelun-Biotech Announce NMPA Approval of IND Application for HBM7575/SKB575 for the Treatment of Asthma July 17, 2026
Biotech Ascletis Selects for Clinical Development a Fixed-Dose Combination of First-in-Class Oral Small Molecule GIPR Agonist, ASC48, and Oral Small Molecule GLP-1R Agonist, ASC30 July 16, 2026
Search
Biotech
July 25, 2026
July 24, 2026
July 23, 2026
July 22, 2026
July 21, 2026
July 20, 2026
July 19, 2026
July 18, 2026
July 17, 2026
July 16, 2026
